🇺🇸 FDA

Company profile · Sponsor

Hoth

Hoth Therapeutics

HOTH · NYSE pharma HOBOKEN, NJ, USA
Pipeline
3
Drugs
0
Patents
1

Quick answer

Hoth (HOTH) is a pharma company. headquartered in HOBOKEN, NJ, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker HOTH
Exchange NYSE
Company type pharma
Headquarters HOBOKEN, NJ, USA
SEC CIK 0001711786

Pipeline (3)

Search pipeline →

  1. HT-001 2% Topical Gel

    Hoth

    Acneiform Eruption Due to Chemical

    phase 2 small molecule active

    1 trial

  2. HT-001, HT-001, The corresponding placebo is formulated using the same excipients as HT-001 and is identical in color and physical appearance., HT-001

    Hoth

    Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors

    phase 2 small molecule active

    1 trial

  3. BioLexa- Cohort 1

    Hoth

    Atopic Dermatitis

    phase 1 small molecule completed

    1 trial

Patents (1)

Search patents →

  1. US 12144815

    Use of aprepitant for treating Alzheimer's disease

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Hoth?

Hoth (HOTH) is a pharma company. headquartered in HOBOKEN, NJ, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Hoth sponsor?

We track 3 ClinicalTrials.gov-linked programs for Hoth, including HT-001 2% Topical Gel and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Hoth company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.